A Comparison of Hickman Line- and Port-a-Cath-associated Complications in Patients with Solid Tumours Undergoing Chemotherapy

Clinical Oncology

Volumn 19, Issue 7, 2007, Pages 551-556

  Ng, F ^a   Mastoroudes, H ^a   Paul, E ^b   Davies, N ^c   Tibballs, J ^c   Hochhauser, D ^a   Mayer, A ^a   Begent, R ^a   Meyer, T ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; complication; Hickman line; infection; infusion; Port a Cath

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; NAVELBINE; OXALIPLATIN; PACLITAXEL; TRASTUZUMAB;

ADULT; ANUS CANCER; APPENDIX CANCER; ARTICLE; BILE DUCT CARCINOMA; BREAST CANCER; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG INFUSION; ESOPHAGUS CANCER; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS CATHETER; KLEBSIELLA; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PANCREAS CANCER; PATIENT SAFETY; PRIORITY JOURNAL; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; STOMACH CANCER; TESTIS CANCER; TIME; VASCULAR ACCESS; VEIN CATHETERIZATION;

AMBULATORY CARE; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 34547496638     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.04.003     Document Type: Article

References (14)

1. Hickman R.O., Buckner C.D., Clift R.A., Sanders J.E., Stewart P., and Thomas E.D. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148 6 (1979) 871-875
2. O'Neill V.J., Jeffrey Evans T.R., Preston J., Moss J., and Kaye S.B. A retrospective analysis of Hickman line-associated complications in patients with solid tumours undergoing infusional chemotherapy. Acta Oncol 38 8 (1999) 1103-1107
3. Ingram J., Weitzman S., Greenberg M.L., Parkin P., and Filler R. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 13 2 (1991) 130-136
4. Ross M.N., Haase G.M., Poole M.A., Burrington J.D., and Odom L.F. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 167 2 (1988) 141-144
5. Stanislav G.V., Fitzgibbons Jr. R.J., Bailey Jr. R.T., Mailliard J.A., Johnson P.S., and Feole J.B. Reliability of implantable central venous access devices in patients with cancer. Arch Surg 122 11 (1987) 1280-1283
6. Pegues D., Axelrod P., McClarren C., et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 49 3 (1992) 156-162
7. Greene F.L., Moore W., Strickland G., and McFarland J. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). South Med J 81 5 (1988) 580-583
8. Mueller B.U., Skelton J., Callender D.P., et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 10 12 (1992) 1943-1948
9. Carde P., Cosset-Delaigue M.F., Laplanche A., and Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 25 6 (1989) 939-944
10. Raaf J.H. Results from use of 826 vascular access devices in cancer patients. Cancer 55 6 (1985) 1312-1321
11. Poorter R.L., Lauw F.N., Bemelman W.A., Bakker P.J., Taat C.W., and Veenhof C.H. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. Eur J Cancer 32A 13 (1996) 2262-2266
12. Capaccioli L., Nistri M., Distante V., Rontini M., Manetti A., and Stecco A. Insertion and management of long-term central venous devices: role of radiologic imaging techniques. Radiol Med (Torino) 96 4 (1998) 369-374
13. Schwarz R.E., Groeger J.S., and Coit D.G. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79 8 (1997) 1635-1640
14. McCready D., Broadwater R., Ross M., Pollock R., Ota D., and Balch C. A case-control comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients. J Surg Res 51 5 (1991) 377-381